Patents Examined by Melissa L Fisher
  • Patent number: 11400042
    Abstract: The present invention relates to a process for treating keratin fibres, in particular human keratin fibres such as the hair, comprising: 1) a step of applying to the keratin fibres a composition comprising: a) one or more compounds chosen from urea and/or urea derivatives, b) one or more polyols, c) one or more amino silicones, 2) a step of heat treatment of the keratin fibres, the heat treatment step 2) preferably being after step 1). The present invention also relates to a composition that may be used in the process according to the invention.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: August 2, 2022
    Assignee: L'OREAL
    Inventors: Guillaume Ronchard, Manon Chaumontet, Renaud Souchay
  • Patent number: 11395496
    Abstract: A multipurpose mosquito repellent composition obtained by a process of forming a foundation mixture by mixing an anti-insect extract/essential oil with at least two odorless and anti-insect effect prolonging extract/essential oils; and mixing the foundation mixture with a plurality of aromatic and medicinal oils in a specific order with each of the plurality of aromatic and medicinal oils having a specific predetermined percentage (%) by weight relative to the total weight of the multipurpose mosquito repellent composition.
    Type: Grant
    Filed: April 10, 2019
    Date of Patent: July 26, 2022
    Inventor: Loc Thanh Pham
  • Patent number: 11376198
    Abstract: The present invention primarily relates to a method for producing a powder containing a plurality of capsules incorporated into crystals, wherein these capsules contain one or more ingredients. Further, the present invention relates to the respective powder, as well as product containing this powder, the use of the powder as well as methods for producing respective products and methods for perfuming substrates.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: July 5, 2022
    Assignee: SYMRISE AG
    Inventors: Kolja Behrens, Patrick Ott, Nicolas Pichon, Nadine Schmidtmeier, Jörn Wiedemann
  • Patent number: 11376199
    Abstract: Described herein, an anhydrous cosmetic composition includes one or more water-absorbing components; a malodour-controlling component; a cosmetically acceptable carrier; wherein the anhydrous cosmetic composition has a burst resistance pressure greater than about 137.9 mBar (2 psi); wherein the anhydrous cosmetic composition has a water vapor sorption per 100 g of the composition from about 2.0 g to about 15 g; and wherein the anhydrous cosmetic composition is essentially free of aluminium-based antiperspirant actives.
    Type: Grant
    Filed: March 10, 2020
    Date of Patent: July 5, 2022
    Assignee: The Procter & Gamble Company
    Inventors: Stevan David Jones, Dean Zimmerman, Mahmoud Eljack, Jorge Max Sunkel, William Richard Mueller, Scott Vierling, Steven Robert Sealschott, Larry Wayne Marshall, Timothy Roy Nijakowski, Carl Edward Catrenich
  • Patent number: 11376301
    Abstract: Compositions and methods for improving gastrointestinal function and reducing the presence of gas bubbles in a gastrointestinal tract. A method includes administering a composition to a user during an endoscopy procedure for reducing a presence of gas bubbles in a gastrointestinal tract of a user. The composition includes an effective amount of ginger root extract for reducing the presence of the gas bubbles in the gastrointestinal tract of the user, and further includes propylene glycol and sodium chloride.
    Type: Grant
    Filed: January 20, 2020
    Date of Patent: July 5, 2022
    Assignee: Advanced Health Solutions LLC
    Inventor: Jill Parks
  • Patent number: 11364261
    Abstract: A method for alleviating, preventing or treating symptoms of a viral infection such as common cold and flu, comprising administering to a subject in need thereof at least one solid form that releases molecular hydrogen upon exposure to the subject's gastric juice.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: June 21, 2022
    Assignee: H2 Universe, LLC
    Inventors: Vladimir L. Safonov, Marina Yu Safonov
  • Patent number: 11344483
    Abstract: A water-based liquid cosmetic comprising: sodium polyaspartate; at least one brilliant powder selected from the group consisting of a glass powder coated with a metal or a metal oxide, an aluminum powder, and a resin film powder coated with a metal; a water-soluble dispersant; and at least one metal oxide selected from the group consisting of yellow iron oxide, red iron oxide, black iron oxide, titanium dioxide, titanium oxynitride, and Prussian blue.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: May 31, 2022
    Inventor: Kazunori Ogino
  • Patent number: 11331409
    Abstract: Disclosed herein is a technology for healing bone defects using bioactive silicate glass (BSG) and a 3D osteomimetic composite porous scaffold containing microspheres comprised of poly(lactide-co-glycolide) (PLGA).
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: May 17, 2022
    Assignee: Purdue Research Foundation
    Inventors: Meng Deng, Dong Qiu, Jessica Lynn Zuponcic
  • Patent number: 11330815
    Abstract: Foamable formulations of agriculturally active ingredients are provided, as well as methods for using them. The formulations allow improved delivery active ingredients by the ability to deliver high amounts of active ingredient with a low volume of formulation used.
    Type: Grant
    Filed: May 28, 2020
    Date of Patent: May 17, 2022
    Assignee: FMC Corporation
    Inventors: Timothy M. Martin, Shawn Grant, Neil Destefano, Adam Prestegord, Michael Harper
  • Patent number: 11331260
    Abstract: The present invention may provide an oil in water (O/W) cosmetic composition having water resistance and ease of facial cleansing, using an A-B-A type triblock copolymer which is included in the cosmetic, and thus may adjust the surfactant power. Further, it is possible to provide a method for imparting water resistance and ease of facial cleansing, using the A-B-A type triblock copolymer.
    Type: Grant
    Filed: October 30, 2019
    Date of Patent: May 17, 2022
    Assignee: COSMAX, INC.
    Inventors: Ji Hyun Lee, Jun Bae Lee, Sun Young Kim, Sung Yong Kim, So Youn An, Chun Ho Park, Myeong Sam Park
  • Patent number: 11324680
    Abstract: The present invention relates to topical compositions comprising erythrulose and a caprylate, characterized in that the amount of the caprylate in the composition is 5 higher than the amount of erythrulose.
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: May 10, 2022
    Assignee: DSM IP ASSETS B.V.
    Inventors: Christine Mendrok-Edinger, Sebastien Mongiat, Thomas Rudolph
  • Patent number: 11318214
    Abstract: A magnetic microparticle drug carrier comprising mesoporous iron oxide is described. The drug carrier has an average diameter in a range of 0.5-1.2 ?m, a BET surface area ranging from 50-300 m2/g, and a pore volume ranging from 0.15-0.65 cm3/g. The drug carrier is made using a hard mesoporous silica template which is completely removed from the deposited iron oxide. The drug carrier may be loaded with high amounts of hydrophilic anticancer chemotherapeutic drugs and/or hydrophobic hormonal anticancer drugs, and released in a pH-controlled manner inside cancerous cells. Compared to free drugs, the drug microparticle carrier displays enhanced drug accumulation inside tumor tissues, deeply penetrates into a tumor region and kills the tumor cells inside. The designed carriers described here entrap and release different kinds of anticancer drugs in a controlled manner for synergistic combinatorial chemo/hormonal cancer therapy.
    Type: Grant
    Filed: June 23, 2020
    Date of Patent: May 3, 2022
    Assignees: National Guard Health Affairs, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center
    Inventors: Kheireddine El-Boubbou, Rizwan Ali, Abdulmohsen Alkushi
  • Patent number: 11311646
    Abstract: A bioactive glass composition for use in treating bone cancer includes 0.5-10 mol % gallium oxide or 1.0-20 mol % gallium nitrate/halide; 25 to 75 mol % silicon dioxide; 10 to 30 mol % calcium oxide and/or strontium oxide; up to 30 mol % sodium oxide; and up to 15 mol % phosphorous pentoxide. It may further comprise magnesium and/or potassium oxide. The bioactive glass composition may be positioned within a patient's bone post-surgery to promote apatite formation and to release gallium ions having a toxic effect on any remaining cancerous cells.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: April 26, 2022
    Inventor: Richard Martin
  • Patent number: 11304937
    Abstract: The present invention provides a particle comprising pirfenidone and a lipid, particularly magnesium stearate, and having a mean particle diameter of 5 ?m or less, and a powder formulation comprising the particle and a carrier.
    Type: Grant
    Filed: July 12, 2017
    Date of Patent: April 19, 2022
    Assignee: SHIONOGI & CO., LTD.
    Inventors: Takeshi Funaki, Yukiko Nishino, Yuki Masuda, Koichi Tsubone
  • Patent number: 11298357
    Abstract: The present invention relates generally to a feed supplement preparation for administration to ruminant animals and, more particularly, to a formulation for an oral bovine supplement for neonatal calves that delivers naturally occurring caffeine, antioxidants and other electrolytes in a stable liquid form of moderate viscosity.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: April 12, 2022
    Assignee: TechMix, LLC
    Inventors: Nathan C. Upah, Aaron N. Fritchen, Dennis M. McKilligan, Bradley W. Kolstad
  • Patent number: 11298298
    Abstract: A method for producing a nonaqueous composition for external use on the skin including a strongly hydrophilic amphiphilic solid active ingredient-surfactant complex dissolved or dispersed in an oil phase, the method including the steps of: dissolving a surfactant in an oil phase to obtain a surfactant solution; mixing the obtained surfactant solution with a strongly hydrophilic amphiphilic solid active ingredient to obtain a suspension; and allowing the obtained suspension to stand still to obtain a transparent composition. Unlike conventional methods for preparing S/O formulations, the strongly hydrophilic amphiphilic solid active ingredient can be solubilized in an oil phase without the process of emulsification and freeze drying.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: April 12, 2022
    Inventors: Masayoshi Miyamoto, Yoshihito Oda, Masahiro Goto
  • Patent number: 11273108
    Abstract: An elastomer improves the feel of inorganic powder on the skin. An emulsion cosmetic is characterized by containing: (A) 0.5-20 mass % of an inorganic powder having an elastomer coating layer containing (a1) and (a2); and (B) 20-80 mass % of an oil component. The elastomer is characterized by comprising: (a1) a silicone polymer having an amino group; and (a2) a carboxyl group-containing silicone polymer or a carboxyl group-containing acrylic polymer, wherein the molar ratio of the amino group to the carboxyl group, Y/X is in the range of 0.1-1.2 (Y is the molar amount of the carboxyl group contained in the component (a2), and X is the molar amount of the amino group contained in the component (a1)).
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: March 15, 2022
    Inventors: Mayo Shinke, Shoko Ogawa, Tomo Osawa, Tomoko Ikeda
  • Patent number: 11246966
    Abstract: An antimicrobial article, a cell culture article, an antithrombotic article, or a biopharmaceutical article that can reduce adhesion of proteins, blood components, cells, or bacteria containing a copolymer that contains a polymerized unit (A) represented by —CH2—CHOH— and a polymerized unit (B) represented by —CH2—CX2—, wherein Xs are the same as or different from each other, and are each an alkyl group having a linear, branched, or cyclic structure, and optionally containing an oxygen atom between carbon atoms, an alkoxy group having a linear, branched, or cyclic structure, and optionally containing a hetero atom between carbon atoms, a siloxy group having a carbon number of 3 or greater, an ester group containing an aromatic ring or an alkyl group and having a linear, branched, or cyclic structure, or H, excluding those in which both Xs are H.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: February 15, 2022
    Inventors: Tsuyoshi Ando, Masayasu Totani, Masao Tanihara, Shota Shibutani, Yoshito Tanaka, Takuma Kawabe, Haruhiko Mohri
  • Patent number: 11235002
    Abstract: Therapeutically-active compositions and formulations for treating pain, pruritus, irritation, inflammation, and tissue damage due to the irritation and inflammation, and therapeutically-active compositions and formulations for wound management, including wounds that are at high risk for infection. Strontium and beta hydroxybutyrate based compositions and formulations which can be topically applied.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: February 1, 2022
    Assignee: Galleon Labs LLC
    Inventors: Gary S. Hahn, Siva Gudi
  • Patent number: 11235000
    Abstract: The invention provides CaO2 nanoparticles having a pH-responsive coating for use in a method of adjuvant therapy of hypoxic tumour cells or tissues. The nanoparticles find particular use in enhancing cancer therapies that depend on oxygen to exert their effect, such as photodynamic therapy (PDT), sonodynamic therapy (SDT), and radiotherapy. The invention also provides pharmaceutical compositions containing the coated CaO2 nanoparticles, together with at least one photosensitiser, sonosensitiser, or radiosensitiser and, optionally, at least one pharmaceutical carrier or excipient.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: February 1, 2022
    Inventors: Anthony Mchale, John Callan, Yingjie Sheng